Recursion

Recursion is a clinical-stage TechBio company that runs its Recursion OS drug discovery and development platform. The platform combines automated wet labs, cell imaging and other biological data, and machine learning models to identify targets, design compounds and support clinical trial enrollment.

Its pipeline focuses on oncology and rare diseases, with programs listed from preclinical to Phase 1/2 and Phase 3. The website describes pharmaceutical partnerships, technology partnerships and data partnerships, including patient-data partners Tempus and Helix, as ways to expand its therapeutic reach. The website does not state a revenue model explicitly.

The company was founded more than a decade ago and is headquartered in Salt Lake City, Utah. The team page cites about 580 employees. The careers page lists 14 open roles across Salt Lake City, New York, remote US and UK, with openings in computational biology, chemistry, clinical pharmacology, engineering and business development.

Product: Recursion OS, an AI drug discovery and development platform spanning target identification to clinical trial enrollment, plus an internal pipeline of drug candidates.